25 XP   0   0   10

Dashenlin Pharm Grp Co Ltd
Buy, Hold or Sell?

Let's analyse Dashenlin Pharm Grp Co Ltd together

PenkeI guess you are interested in Dashenlin Pharm Grp Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dashenlin Pharm Grp Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dashenlin Pharm Grp Co Ltd

I send you an email if I find something interesting about Dashenlin Pharm Grp Co Ltd.

Quick analysis of Dashenlin Pharm Grp Co Ltd (30 sec.)










What can you expect buying and holding a share of Dashenlin Pharm Grp Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.15
When do you have the money?
1 year
How often do you get paid?
96.8%

What is your share worth?

Current worth
¥6.91
Expected worth in 1 year
¥7.99
How sure are you?
96.8%

+ What do you gain per year?

Total Gains per Share
¥2.17
Return On Investment
10.3%

For what price can you sell your share?

Current Price per Share
¥21.11
Expected price per share
¥19.48 - ¥26.06
How sure are you?
50%

1. Valuation of Dashenlin Pharm Grp Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥21.11

Intrinsic Value Per Share

¥9.90 - ¥11.42

Total Value Per Share

¥16.82 - ¥18.33

2. Growth of Dashenlin Pharm Grp Co Ltd (5 min.)




Is Dashenlin Pharm Grp Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$876.8m$159.5m15.4%

How much money is Dashenlin Pharm Grp Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$44.5m$31m$13.5m30.4%
Net Profit Margin5.4%4.6%--

How much money comes from the company's main activities?

3. Financial Health of Dashenlin Pharm Grp Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#52 / 1031

Most Revenue
#21 / 1031

Most Profit
#43 / 1031

Most Efficient
#146 / 1031

What can you expect buying and holding a share of Dashenlin Pharm Grp Co Ltd? (5 min.)

Welcome investor! Dashenlin Pharm Grp Co Ltd's management wants to use your money to grow the business. In return you get a share of Dashenlin Pharm Grp Co Ltd.

What can you expect buying and holding a share of Dashenlin Pharm Grp Co Ltd?

First you should know what it really means to hold a share of Dashenlin Pharm Grp Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Dashenlin Pharm Grp Co Ltd is ¥21.11. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dashenlin Pharm Grp Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dashenlin Pharm Grp Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.91. Based on the TTM, the Book Value Change Per Share is ¥0.27 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.27 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dashenlin Pharm Grp Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.1%0.040.2%0.030.1%0.030.1%0.020.1%
Usd Book Value Change Per Share0.030.1%0.040.2%0.020.1%0.030.1%0.030.1%
Usd Dividend Per Share0.000.0%0.040.2%0.010.1%0.020.1%0.010.1%
Usd Total Gains Per Share0.030.1%0.080.4%0.040.2%0.050.2%0.050.2%
Usd Price Per Share3.48-4.50-4.62-6.85-5.60-
Price to Earnings Ratio27.87-43.06--87.99-38.93-44.06-
Price-to-Total Gains Ratio111.28-95.52-252.29-201.84-225.11-
Price to Book Ratio3.64-4.99-6.05-11.35-10.71-
Price-to-Total Gains Ratio111.28-95.52-252.29-201.84-225.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.921624
Number of shares342
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.02
Usd Book Value Change Per Share0.040.03
Usd Total Gains Per Share0.080.05
Gains per Quarter (342 shares)25.6516.52
Gains per Year (342 shares)102.6166.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1525193254156
21031021965181122
315515329976122188
4206204402102163254
5258255505127203320
6309307608153244386
7361358711178284452
8412409814204325518
9464460917229366584
105155111020255406650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%30.01.00.096.8%30.01.00.096.8%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%17.02.01.085.0%25.03.03.080.6%25.03.03.080.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%19.00.01.095.0%30.00.01.096.8%30.00.01.096.8%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.00.01.095.0%30.00.01.096.8%30.00.01.096.8%

Fundamentals of Dashenlin Pharm Grp Co Ltd

About Dashenlin Pharm Grp Co Ltd

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

Fundamental data was last updated by Penke on 2024-03-27 21:46:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Dashenlin Pharm Grp Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dashenlin Pharm Grp Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Dashenlin Pharm Grp Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 4.5% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dashenlin Pharm Grp Co Ltd:

  • The MRQ is 4.5%. The company is making a profit. +1
  • The TTM is 5.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.5%TTM5.4%-0.9%
TTM5.4%YOY4.6%+0.8%
TTM5.4%5Y5.7%-0.4%
5Y5.7%10Y6.1%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5%-171.8%+176.3%
TTM5.4%-205.8%+211.2%
YOY4.6%-262.1%+266.7%
5Y5.7%-455.6%+461.3%
10Y6.1%-589.0%+595.1%
1.1.2. Return on Assets

Shows how efficient Dashenlin Pharm Grp Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dashenlin Pharm Grp Co Ltd to the Biotechnology industry mean.
  • 1.2% Return on Assets means that Dashenlin Pharm Grp Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dashenlin Pharm Grp Co Ltd:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.5%-0.3%
TTM1.5%YOY1.2%+0.3%
TTM1.5%5Y1.8%-0.3%
5Y1.8%10Y2.2%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%-12.5%+13.7%
TTM1.5%-12.2%+13.7%
YOY1.2%-11.2%+12.4%
5Y1.8%-13.4%+15.2%
10Y2.2%-14.7%+16.9%
1.1.3. Return on Equity

Shows how efficient Dashenlin Pharm Grp Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dashenlin Pharm Grp Co Ltd to the Biotechnology industry mean.
  • 3.8% Return on Equity means Dashenlin Pharm Grp Co Ltd generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dashenlin Pharm Grp Co Ltd:

  • The MRQ is 3.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.8%TTM4.8%-1.1%
TTM4.8%YOY3.8%+1.0%
TTM4.8%5Y4.6%+0.3%
5Y4.6%10Y5.6%-1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8%-15.8%+19.6%
TTM4.8%-15.7%+20.5%
YOY3.8%-13.9%+17.7%
5Y4.6%-18.3%+22.9%
10Y5.6%-19.2%+24.8%

1.2. Operating Efficiency of Dashenlin Pharm Grp Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dashenlin Pharm Grp Co Ltd is operating .

  • Measures how much profit Dashenlin Pharm Grp Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dashenlin Pharm Grp Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dashenlin Pharm Grp Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.0%-3.0%
TTM3.0%YOY7.2%-4.2%
TTM3.0%5Y7.0%-4.1%
5Y7.0%10Y4.5%+2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM3.0%-210.1%+213.1%
YOY7.2%-279.7%+286.9%
5Y7.0%-459.9%+466.9%
10Y4.5%-596.9%+601.4%
1.2.2. Operating Ratio

Measures how efficient Dashenlin Pharm Grp Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.56 means that the operating costs are ¥1.56 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Dashenlin Pharm Grp Co Ltd:

  • The MRQ is 1.563. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.548. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.563TTM1.548+0.015
TTM1.548YOY1.539+0.010
TTM1.5485Y1.453+0.096
5Y1.45310Y1.145+0.308
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5632.861-1.298
TTM1.5483.193-1.645
YOY1.5393.615-2.076
5Y1.4535.560-4.107
10Y1.1457.396-6.251

1.3. Liquidity of Dashenlin Pharm Grp Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dashenlin Pharm Grp Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.07 means the company has ¥1.07 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Dashenlin Pharm Grp Co Ltd:

  • The MRQ is 1.073. The company is just able to pay all its short-term debts.
  • The TTM is 1.091. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.073TTM1.091-0.017
TTM1.091YOY1.138-0.047
TTM1.0915Y1.192-0.101
5Y1.19210Y0.769+0.423
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0733.986-2.913
TTM1.0914.440-3.349
YOY1.1385.552-4.414
5Y1.1926.158-4.966
10Y0.7696.492-5.723
1.3.2. Quick Ratio

Measures if Dashenlin Pharm Grp Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dashenlin Pharm Grp Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.12 means the company can pay off ¥0.12 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dashenlin Pharm Grp Co Ltd:

  • The MRQ is 0.122. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.140. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.122TTM0.140-0.019
TTM0.140YOY0.180-0.040
TTM0.1405Y0.175-0.035
5Y0.17510Y0.158+0.017
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1223.638-3.516
TTM0.1404.168-4.028
YOY0.1805.515-5.335
5Y0.1756.012-5.837
10Y0.1586.209-6.051

1.4. Solvency of Dashenlin Pharm Grp Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dashenlin Pharm Grp Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dashenlin Pharm Grp Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.63 means that Dashenlin Pharm Grp Co Ltd assets are financed with 63.3% credit (debt) and the remaining percentage (100% - 63.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dashenlin Pharm Grp Co Ltd:

  • The MRQ is 0.633. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.645. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.633TTM0.645-0.012
TTM0.645YOY0.644+0.000
TTM0.6455Y0.584+0.060
5Y0.58410Y0.580+0.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6330.335+0.298
TTM0.6450.330+0.315
YOY0.6440.267+0.377
5Y0.5840.367+0.217
10Y0.5800.378+0.202
1.4.2. Debt to Equity Ratio

Measures if Dashenlin Pharm Grp Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dashenlin Pharm Grp Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 198.5% means that company has ¥1.98 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dashenlin Pharm Grp Co Ltd:

  • The MRQ is 1.985. The company is just able to pay all its debts with equity.
  • The TTM is 2.066. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.985TTM2.066-0.082
TTM2.066YOY1.982+0.084
TTM2.0665Y1.576+0.490
5Y1.57610Y1.521+0.055
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9850.376+1.609
TTM2.0660.398+1.668
YOY1.9820.334+1.648
5Y1.5760.429+1.147
10Y1.5210.476+1.045

2. Market Valuation of Dashenlin Pharm Grp Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Dashenlin Pharm Grp Co Ltd generates.

  • Above 15 is considered overpriced but always compare Dashenlin Pharm Grp Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 27.87 means the investor is paying ¥27.87 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dashenlin Pharm Grp Co Ltd:

  • The EOD is 23.393. Based on the earnings, the company is fair priced.
  • The MRQ is 27.871. Based on the earnings, the company is overpriced. -1
  • The TTM is 43.064. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD23.393MRQ27.871-4.477
MRQ27.871TTM43.064-15.194
TTM43.064YOY-87.986+131.051
TTM43.0645Y38.934+4.130
5Y38.93410Y44.064-5.130
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD23.393-2.643+26.036
MRQ27.871-2.418+30.289
TTM43.064-2.742+45.806
YOY-87.986-4.123-83.863
5Y38.934-6.257+45.191
10Y44.064-6.478+50.542
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dashenlin Pharm Grp Co Ltd:

  • The EOD is 8.405. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 10.013. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 515.139. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD8.405MRQ10.013-1.609
MRQ10.013TTM515.139-505.126
TTM515.139YOY4.335+510.805
TTM515.1395Y174.182+340.957
5Y174.18210Y100.230+73.952
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.405-3.244+11.649
MRQ10.013-2.939+12.952
TTM515.139-3.478+518.617
YOY4.335-5.592+9.927
5Y174.182-8.473+182.655
10Y100.230-8.881+109.111
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dashenlin Pharm Grp Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.64 means the investor is paying ¥3.64 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Dashenlin Pharm Grp Co Ltd:

  • The EOD is 3.055. Based on the equity, the company is fair priced.
  • The MRQ is 3.639. Based on the equity, the company is fair priced.
  • The TTM is 4.994. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.055MRQ3.639-0.585
MRQ3.639TTM4.994-1.355
TTM4.994YOY6.051-1.056
TTM4.9945Y11.345-6.351
5Y11.34510Y10.709+0.636
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.0552.124+0.931
MRQ3.6392.041+1.598
TTM4.9942.118+2.876
YOY6.0512.915+3.136
5Y11.3453.682+7.663
10Y10.7094.114+6.595
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dashenlin Pharm Grp Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2060.270-24%0.168+23%0.215-4%0.223-7%
Book Value Per Share--6.9116.575+5%5.563+24%4.853+42%3.736+85%
Current Ratio--1.0731.091-2%1.138-6%1.192-10%0.769+40%
Debt To Asset Ratio--0.6330.645-2%0.644-2%0.584+8%0.580+9%
Debt To Equity Ratio--1.9852.066-4%1.982+0%1.576+26%1.521+31%
Dividend Per Share--0.0200.272-93%0.090-78%0.134-85%0.108-82%
Eps--0.2260.266-15%0.197+15%0.211+7%0.173+31%
Free Cash Flow Per Share--0.6280.451+39%0.277+127%0.292+115%0.205+206%
Free Cash Flow To Equity Per Share--0.6280.051+1138%0.113+454%0.160+291%0.185+239%
Gross Profit Margin--1.0001.0000%1.0000%0.950+5%0.968+3%
Intrinsic Value_10Y_max--11.420--------
Intrinsic Value_10Y_min--9.905--------
Intrinsic Value_1Y_max--1.168--------
Intrinsic Value_1Y_min--1.147--------
Intrinsic Value_3Y_max--3.491--------
Intrinsic Value_3Y_min--3.333--------
Intrinsic Value_5Y_max--5.793--------
Intrinsic Value_5Y_min--5.378--------
Market Cap24041124513.280-19%28643387789.85037010954737.778-23%38051827228.800-25%56368187611.364-49%46076551436.424-38%
Net Profit Margin--0.0450.054-17%0.046-2%0.057-22%0.061-26%
Operating Margin---0.030-100%0.072-100%0.070-100%0.045-100%
Operating Ratio--1.5631.548+1%1.539+2%1.453+8%1.145+37%
Pb Ratio3.055-19%3.6394.994-27%6.051-40%11.345-68%10.709-66%
Pe Ratio23.393-19%27.87143.064-35%-87.986+416%38.934-28%44.064-37%
Price Per Share21.110-19%25.15032.498-23%33.413-25%49.496-49%40.459-38%
Price To Free Cash Flow Ratio8.405-19%10.013515.139-98%4.335+131%174.182-94%100.230-90%
Price To Total Gains Ratio93.406-19%111.28295.517+17%252.292-56%201.835-45%225.112-51%
Quick Ratio--0.1220.140-13%0.180-32%0.175-31%0.158-23%
Return On Assets--0.0120.015-21%0.012-4%0.018-34%0.022-46%
Return On Equity--0.0380.048-22%0.038-1%0.046-18%0.056-33%
Total Gains Per Share--0.2260.542-58%0.259-13%0.349-35%0.331-32%
Usd Book Value--1089320820.5691036435641.337+5%876878516.821+24%764908688.706+42%588880676.533+85%
Usd Book Value Change Per Share--0.0290.037-24%0.023+23%0.030-4%0.031-7%
Usd Book Value Per Share--0.9560.910+5%0.770+24%0.672+42%0.517+85%
Usd Dividend Per Share--0.0030.038-93%0.013-78%0.019-85%0.015-82%
Usd Eps--0.0310.037-15%0.027+15%0.029+7%0.024+31%
Usd Free Cash Flow--98974145.57071114605.203+39%43584799.781+127%46025535.389+115%32382777.216+206%
Usd Free Cash Flow Per Share--0.0870.062+39%0.038+127%0.040+115%0.028+206%
Usd Free Cash Flow To Equity Per Share--0.0870.007+1138%0.016+454%0.022+291%0.026+239%
Usd Market Cap3327291632.638-19%3964244870.1155122316135.708-23%5266372888.466-25%7801357165.413-49%6376994718.801-38%
Usd Price Per Share2.922-19%3.4814.498-23%4.624-25%6.850-49%5.599-38%
Usd Profit--35559501.09944524845.476-20%31006335.559+15%32981801.813+8%27031313.089+32%
Usd Revenue--793207995.896835716300.859-5%665076130.607+19%563665862.063+41%450329036.430+76%
Usd Total Gains Per Share--0.0310.075-58%0.036-13%0.048-35%0.046-32%
 EOD+4 -4MRQTTM+15 -20YOY+17 -185Y+17 -1910Y+18 -18

3.2. Fundamental Score

Let's check the fundamental score of Dashenlin Pharm Grp Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1523.393
Price to Book Ratio (EOD)Between0-13.055
Net Profit Margin (MRQ)Greater than00.045
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.122
Current Ratio (MRQ)Greater than11.073
Debt to Asset Ratio (MRQ)Less than10.633
Debt to Equity Ratio (MRQ)Less than11.985
Return on Equity (MRQ)Greater than0.150.038
Return on Assets (MRQ)Greater than0.050.012
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Dashenlin Pharm Grp Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.634
Ma 20Greater thanMa 5021.984
Ma 50Greater thanMa 10023.307
Ma 100Greater thanMa 20024.296
OpenGreater thanClose21.070
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets21,432,129
Total Liabilities13,561,313
Total Stockholder Equity6,833,544
 As reported
Total Liabilities 13,561,313
Total Stockholder Equity+ 6,833,544
Total Assets = 21,432,129

Assets

Total Assets21,432,129
Total Current Assets9,911,752
Long-term Assets11,520,376
Total Current Assets
Cash And Cash Equivalents 3,694,138
Short-term Investments 45,911
Net Receivables 1,077,812
Inventory 4,278,437
Other Current Assets 249,772
Total Current Assets  (as reported)9,911,752
Total Current Assets  (calculated)9,346,070
+/- 565,682
Long-term Assets
Property Plant Equipment 6,293,957
Goodwill 2,742,629
Intangible Assets 713,222
Long-term Assets Other 780,080
Long-term Assets  (as reported)11,520,376
Long-term Assets  (calculated)10,529,889
+/- 990,487

Liabilities & Shareholders' Equity

Total Current Liabilities9,233,326
Long-term Liabilities4,327,987
Total Stockholder Equity6,833,544
Total Current Liabilities
Short Long Term Debt 238,502
Accounts payable 6,472,297
Other Current Liabilities 18,525
Total Current Liabilities  (as reported)9,233,326
Total Current Liabilities  (calculated)6,729,324
+/- 2,504,002
Long-term Liabilities
Long term Debt 1,633,127
Capital Lease Obligations Min Short Term Debt2,678,840
Long-term Liabilities  (as reported)4,327,987
Long-term Liabilities  (calculated)4,311,967
+/- 16,020
Total Stockholder Equity
Retained Earnings 3,785,025
Total Stockholder Equity (as reported)6,833,544
Total Stockholder Equity (calculated)3,785,025
+/- 3,048,519
Other
Capital Stock1,138,902
Common Stock Shares Outstanding 1,138,902
Net Invested Capital 8,705,174
Net Working Capital 678,426
Property Plant and Equipment Gross 6,293,957



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-03-312015-12-312015-06-302015-03-312014-12-312013-12-312012-12-31
> Total Assets 
996,506
1,680,847
2,365,181
2,476,067
2,476,067
2,658,415
0
3,580,129
3,701,855
3,988,429
5,294,834
5,822,764
5,664,048
5,769,048
6,372,289
0
6,912,015
7,697,734
7,909,617
8,671,928
9,165,407
9,031,545
9,919,262
12,331,926
15,506,607
15,581,447
16,088,906
17,335,682
17,719,840
17,955,274
18,246,104
20,841,243
21,155,366
20,831,059
21,432,129
21,432,12920,831,05921,155,36620,841,24318,246,10417,955,27417,719,84017,335,68216,088,90615,581,44715,506,60712,331,9269,919,2629,031,5459,165,4078,671,9287,909,6177,697,7346,912,01506,372,2895,769,0485,664,0485,822,7645,294,8343,988,4293,701,8553,580,12902,658,4152,476,0672,476,0672,365,1811,680,847996,506
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,295,236
5,090,248
5,193,857
5,468,043
5,772,105
5,606,282
6,397,769
8,297,310
7,966,331
7,409,919
7,527,880
7,867,867
8,265,749
8,535,113
8,682,151
10,669,631
10,524,523
9,443,754
9,911,752
9,911,7529,443,75410,524,52310,669,6318,682,1518,535,1138,265,7497,867,8677,527,8807,409,9197,966,3318,297,3106,397,7695,606,2825,772,1055,468,0435,193,8575,090,2484,295,2360000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,449,901
1,731,266
1,677,091
1,716,089
2,081,032
2,042,959
2,632,999
3,750,372
3,427,924
2,701,829
2,657,779
2,792,361
2,982,490
3,344,969
3,715,185
4,493,052
4,369,114
3,312,763
3,694,138
3,694,1383,312,7634,369,1144,493,0523,715,1853,344,9692,982,4902,792,3612,657,7792,701,8293,427,9243,750,3722,632,9992,042,9592,081,0321,716,0891,677,0911,731,2661,449,9010000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
661,552
912,407
0
0
0
0
689,978
618,428
769,656
336,002
109,370
82,952
94,905
56,358
91,987
59,267
40,733
45,911
45,91140,73359,26791,98756,35894,90582,952109,370336,002769,656618,428689,9780000912,407661,55200000000000000000
       Net Receivables 
60,325
89,753
160,629
126,612
126,612
121,555
0
333,491
322,931
356,513
377,268
428,222
473,928
478,707
454,875
0
349,902
309,045
293,637
575,517
581,979
643,645
629,494
700,444
731,398
819,891
760,576
1,109,504
1,297,456
1,321,461
1,206,502
1,390,046
1,043,100
1,461,016
1,077,812
1,077,8121,461,0161,043,1001,390,0461,206,5021,321,4611,297,4561,109,504760,576819,891731,398700,444629,494643,645581,979575,517293,637309,045349,9020454,875478,707473,928428,222377,268356,513322,931333,4910121,555126,612126,612160,62989,75360,325
       Other Current Assets 
38,140
58,959
108,557
105,698
105,698
149,539
0
97,667
125,549
99,696
619,805
148,571
655,359
139,121
203,832
0
86,800
107,127
100,635
105,912
792,451
135,724
635,816
112,928
285,630
126,247
354,449
224,078
295,508
187,309
255,556
783,060
188,913
494,374
249,772
249,772494,374188,913783,060255,556187,309295,508224,078354,449126,247285,630112,928635,816135,724792,451105,912100,635107,12786,8000203,832139,121655,359148,571619,80599,696125,54997,6670149,539105,698105,698108,55758,95938,140
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,616,779
2,607,486
2,715,761
3,203,884
3,393,302
3,425,263
3,521,494
4,034,616
7,540,276
8,171,528
8,561,025
9,467,815
9,454,091
9,420,161
9,563,953
10,171,612
10,630,843
11,387,305
11,520,376
11,520,37611,387,30510,630,84310,171,6129,563,9539,420,1619,454,0919,467,8158,561,0258,171,5287,540,2764,034,6163,521,4943,425,2633,393,3023,203,8842,715,7612,607,4862,616,7790000000000000000
       Property Plant Equipment 
70,560
355,035
441,663
473,495
473,495
551,583
0
625,156
644,164
681,229
721,228
801,554
833,105
893,132
939,850
983,183
989,230
1,028,672
1,036,638
1,119,130
1,122,950
1,162,589
1,184,123
1,287,160
4,511,151
4,931,734
5,009,377
5,653,707
5,476,069
5,513,211
5,580,409
6,094,975
6,153,744
6,247,889
6,293,957
6,293,9576,247,8896,153,7446,094,9755,580,4095,513,2115,476,0695,653,7075,009,3774,931,7344,511,1511,287,1601,184,1231,162,5891,122,9501,119,1301,036,6381,028,672989,230983,183939,850893,132833,105801,554721,228681,229644,164625,1560551,583473,495473,495441,663355,03570,560
       Goodwill 
11,576
11,576
14,160
14,160
14,160
14,160
0
125,799
125,799
125,799
125,799
161,799
214,883
228,471
321,135
0
641,491
735,361
782,939
983,729
1,145,362
1,145,362
1,220,325
1,333,774
1,472,459
1,544,816
1,785,102
2,059,828
2,149,170
2,211,832
2,322,294
2,363,756
2,592,586
2,727,842
2,742,629
2,742,6292,727,8422,592,5862,363,7562,322,2942,211,8322,149,1702,059,8281,785,1021,544,8161,472,4591,333,7741,220,3251,145,3621,145,362983,729782,939735,361641,4910321,135228,471214,883161,799125,799125,799125,799125,799014,16014,16014,16014,16011,57611,576
       Intangible Assets 
46,505
52,652
64,152
69,354
69,354
78,012
0
192,902
207,707
220,067
224,706
275,920
334,792
483,942
574,428
0
313,024
64,563
279,939
384,828
400,057
399,625
393,574
538,529
616,430
634,621
647,305
676,410
696,621
699,759
700,344
700,554
699,873
701,451
713,222
713,222701,451699,873700,554700,344699,759696,621676,410647,305634,621616,430538,529393,574399,625400,057384,828279,93964,563313,0240574,428483,942334,792275,920224,706220,067207,707192,902078,01269,35469,35464,15252,65246,505
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,742
86,546
143,736
102,038
112,008
63,670
1,255,609
160,019
162,329
200,669
244,524
157,986
257,212
119,519
82,437
94,193
286,052
764,435
780,080
780,080764,435286,05294,19382,437119,519257,212157,986244,524200,669162,329160,0191,255,60963,670112,008102,038143,73686,54677,7420000000000000000
> Total Liabilities 
615,391
1,090,919
1,790,334
1,594,713
1,594,713
1,637,225
0
2,238,044
2,231,998
2,375,294
2,610,344
3,020,093
2,701,066
2,904,109
3,389,985
0
3,624,730
4,297,945
4,330,407
4,340,225
4,328,966
4,194,735
4,768,252
6,759,026
9,729,421
9,973,545
10,213,605
11,399,804
11,309,085
11,599,916
11,604,785
13,977,091
13,571,376
13,195,229
13,561,313
13,561,31313,195,22913,571,37613,977,09111,604,78511,599,91611,309,08511,399,80410,213,6059,973,5459,729,4216,759,0264,768,2524,194,7354,328,9664,340,2254,330,4074,297,9453,624,73003,389,9852,904,1092,701,0663,020,0932,610,3442,375,2942,231,9982,238,04401,637,2251,594,7131,594,7131,790,3341,090,919615,391
   > Total Current Liabilities 
615,041
1,080,569
1,678,984
1,491,043
1,491,043
1,541,235
0
2,193,894
2,202,373
2,345,856
2,587,898
2,997,334
2,671,307
2,874,350
3,360,226
0
3,591,206
3,431,923
3,466,015
4,002,841
4,230,788
4,113,739
4,685,816
5,468,470
6,036,988
6,004,870
6,150,808
7,175,606
7,165,864
7,486,356
7,470,052
9,707,603
9,334,345
8,880,156
9,233,326
9,233,3268,880,1569,334,3459,707,6037,470,0527,486,3567,165,8647,175,6066,150,8086,004,8706,036,9885,468,4704,685,8164,113,7394,230,7884,002,8413,466,0153,431,9233,591,20603,360,2262,874,3502,671,3072,997,3342,587,8982,345,8562,202,3732,193,89401,541,2351,491,0431,491,0431,678,9841,080,569615,041
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
326,020
356,020
170,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000170,000356,020326,0200000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
326,020
356,020
170,000
63,471
180,208
177,849
177,849
190,859
86,572
77,211
142,028
165,438
430,805
594,511
617,771
697,309
692,241
367,889
238,502
238,502367,889692,241697,309617,771594,511430,805165,438142,02877,21186,572190,859177,849177,849180,20863,471170,000356,020326,0200000000000000000
       Accounts payable 
354,326
639,173
1,064,928
1,082,470
1,082,470
1,156,581
0
1,499,572
1,585,550
1,587,675
1,873,011
2,110,965
1,870,429
1,996,424
2,398,527
0
2,805,150
2,626,832
2,799,126
3,199,620
3,315,588
3,162,488
3,744,979
4,214,827
4,146,609
4,019,211
4,103,768
4,737,831
4,504,758
4,720,157
4,635,498
6,127,385
6,140,220
5,957,312
6,472,297
6,472,2975,957,3126,140,2206,127,3854,635,4984,720,1574,504,7584,737,8314,103,7684,019,2114,146,6094,214,8273,744,9793,162,4883,315,5883,199,6202,799,1262,626,8322,805,15002,398,5271,996,4241,870,4292,110,9651,873,0111,587,6751,585,5501,499,57201,156,5811,082,4701,082,4701,064,928639,173354,326
       Other Current Liabilities 
134,520
161,396
200,052
165,338
165,338
204,957
0
313,945
234,391
238,160
246,707
371,189
335,399
339,137
360,502
0
5,362
5,362
5,362
391,650
578,681
509,459
581,142
613,598
778,613
646,824
770,807
877,921
1,084,937
893,269
1,103,276
1,090,731
27,535
1,075,858
18,525
18,5251,075,85827,5351,090,7311,103,276893,2691,084,937877,921770,807646,824778,613613,598581,142509,459578,681391,6505,3625,3625,3620360,502339,137335,399371,189246,707238,160234,391313,9450204,957165,338165,338200,052161,396134,520
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,524
866,022
864,392
337,384
98,177
80,996
82,435
1,290,556
3,692,433
3,968,675
4,062,798
4,224,199
4,143,220
4,113,560
4,134,733
4,269,488
4,237,031
4,315,073
4,327,987
4,327,9874,315,0734,237,0314,269,4884,134,7334,113,5604,143,2204,224,1994,062,7983,968,6753,692,4331,290,55682,43580,99698,177337,384864,392866,02233,5240000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-326,020
-356,020
-170,000
0
0
0
0
0
2,386,413
2,655,864
2,739,607
2,951,928
2,848,942
2,732,590
2,745,282
2,790,076
2,728,170
2,730,553
2,678,840
2,678,8402,730,5532,728,1702,790,0762,745,2822,732,5902,848,9422,951,9282,739,6072,655,8642,386,41300000-170,000-356,020-326,0200000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,765
851,263
856,633
260,446
13,455
109
109
0
0
0
0
0
0
0
0
328
328
0
0
003283280000000010910913,455260,446856,633851,26318,7650000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
462,119
450,104
461,177
462,030
491,730
461,003
475,743
481,508
571,855
527,014
600,120
650,163
669,756
628,900
634,023
657,511
663,031
0
675,492
0
0675,4920663,031657,511634,023628,900669,756650,163600,120527,014571,855481,508475,743461,003491,730462,030461,177450,104462,119000000000000000
> Total Stockholder Equity
328,261
525,643
500,145
779,826
779,826
1,021,190
1,021,190
1,317,395
1,437,138
1,570,262
2,641,701
2,752,775
2,902,288
2,805,767
2,933,260
0
3,223,393
3,331,986
3,512,830
4,239,904
4,744,042
4,727,687
4,992,337
5,384,806
5,542,840
5,317,994
5,506,496
5,478,577
5,861,105
5,813,144
6,033,886
6,211,882
6,713,652
6,569,886
6,833,544
6,833,5446,569,8866,713,6526,211,8826,033,8865,813,1445,861,1055,478,5775,506,4965,317,9945,542,8405,384,8064,992,3374,727,6874,744,0424,239,9043,512,8303,331,9863,223,39302,933,2602,805,7672,902,2882,752,7752,641,7011,570,2621,437,1381,317,3951,021,1901,021,190779,826779,826500,145525,643328,261
   Common Stock
164,900
200,000
200,000
360,000
360,000
360,000
0
360,000
360,000
360,000
400,010
400,010
400,010
400,010
400,010
400,010
400,010
520,013
520,013
539,542
546,951
656,341
656,341
658,621
658,621
790,346
790,337
790,935
790,930
949,118
949,118
949,118
0
1,138,902
0
01,138,9020949,118949,118949,118790,930790,935790,337790,346658,621658,621656,341656,341546,951539,542520,013520,013400,010400,010400,010400,010400,010400,010400,010360,000360,000360,0000360,000360,000360,000200,000200,000164,900
   Retained Earnings 
152,561
254,350
228,851
418,533
418,533
624,285
0
910,474
1,027,713
1,158,890
1,277,178
1,385,435
1,532,444
1,433,395
1,559,420
1,677,063
1,732,043
1,689,894
1,868,314
2,139,719
2,424,468
2,406,280
2,678,604
2,873,730
3,038,817
2,820,533
2,993,216
2,932,604
3,316,828
3,251,326
3,460,377
3,572,863
3,676,871
3,920,838
3,785,025
3,785,0253,920,8383,676,8713,572,8633,460,3773,251,3263,316,8282,932,6042,993,2162,820,5333,038,8172,873,7302,678,6042,406,2802,424,4682,139,7191,868,3141,689,8941,732,0431,677,0631,559,4201,433,3951,532,4441,385,4351,277,1781,158,8901,027,713910,4740624,285418,533418,533228,851254,350152,561
   Capital Surplus 00000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
159,178
159,178
45,711
0
0
0
189,971
189,971
189,962
189,959
189,959
189,957
189,936
189,936
189,936
0
189,935
0
0189,9350189,936189,936189,936189,957189,959189,959189,962189,971189,97100045,711159,178159,17800000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue24,153,650
Cost of Revenue-15,300,187
Gross Profit8,853,4638,853,463
 
Operating Income (+$)
Gross Profit8,853,463
Operating Expense-22,119,529
Operating Income2,034,121-13,266,067
 
Operating Expense (+$)
Research Development74,715
Selling General Administrative5,891,318
Selling And Marketing Expenses-
Operating Expense22,119,5295,966,033
 
Net Interest Income (+$)
Interest Income46,025
Interest Expense-50,619
Other Finance Cost-209,454
Net Interest Income-214,048
 
Pretax Income (+$)
Operating Income2,034,121
Net Interest Income-214,048
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,779,3172,034,121
EBIT - interestExpense = -50,619
1,286,845
1,337,464
Interest Expense50,619
Earnings Before Interest and Taxes (EBIT)-1,829,935
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,779,317
Tax Provision-402,545
Net Income From Continuing Ops1,376,7721,376,772
Net Income1,286,845
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-214,048
 

Technical Analysis of Dashenlin Pharm Grp Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dashenlin Pharm Grp Co Ltd. The general trend of Dashenlin Pharm Grp Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dashenlin Pharm Grp Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dashenlin Pharm Grp Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 21.13 < 23.02 < 26.06.

The bearish price targets are: 21.03 > 20.94 > 19.48.

Tweet this
Dashenlin Pharm Grp Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dashenlin Pharm Grp Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dashenlin Pharm Grp Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dashenlin Pharm Grp Co Ltd. The current macd is -0.65319584.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dashenlin Pharm Grp Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Dashenlin Pharm Grp Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Dashenlin Pharm Grp Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Dashenlin Pharm Grp Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartDashenlin Pharm Grp Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dashenlin Pharm Grp Co Ltd. The current adx is 24.92.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Dashenlin Pharm Grp Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Dashenlin Pharm Grp Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dashenlin Pharm Grp Co Ltd. The current sar is 22.95.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Dashenlin Pharm Grp Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dashenlin Pharm Grp Co Ltd. The current rsi is 33.63. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Dashenlin Pharm Grp Co Ltd Daily Relative Strength Index (RSI) ChartDashenlin Pharm Grp Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dashenlin Pharm Grp Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dashenlin Pharm Grp Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Dashenlin Pharm Grp Co Ltd Daily Stochastic Oscillator ChartDashenlin Pharm Grp Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dashenlin Pharm Grp Co Ltd. The current cci is -135.4871571.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Dashenlin Pharm Grp Co Ltd Daily Commodity Channel Index (CCI) ChartDashenlin Pharm Grp Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dashenlin Pharm Grp Co Ltd. The current cmo is -38.62687029.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Dashenlin Pharm Grp Co Ltd Daily Chande Momentum Oscillator (CMO) ChartDashenlin Pharm Grp Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dashenlin Pharm Grp Co Ltd. The current willr is -82.32758621.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Dashenlin Pharm Grp Co Ltd Daily Williams %R ChartDashenlin Pharm Grp Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dashenlin Pharm Grp Co Ltd.

Dashenlin Pharm Grp Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dashenlin Pharm Grp Co Ltd. The current atr is 0.63018824.

Dashenlin Pharm Grp Co Ltd Daily Average True Range (ATR) ChartDashenlin Pharm Grp Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dashenlin Pharm Grp Co Ltd. The current obv is 71,300,394.

Dashenlin Pharm Grp Co Ltd Daily On-Balance Volume (OBV) ChartDashenlin Pharm Grp Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dashenlin Pharm Grp Co Ltd. The current mfi is 34.53.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Dashenlin Pharm Grp Co Ltd Daily Money Flow Index (MFI) ChartDashenlin Pharm Grp Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dashenlin Pharm Grp Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-09STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Dashenlin Pharm Grp Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dashenlin Pharm Grp Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.634
Ma 20Greater thanMa 5021.984
Ma 50Greater thanMa 10023.307
Ma 100Greater thanMa 20024.296
OpenGreater thanClose21.070
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dashenlin Pharm Grp Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Dashenlin Pharm Grp Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dashenlin Pharm Grp Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dashenlin Pharm Grp Co Ltd

I send you an email if I find something interesting about Dashenlin Pharm Grp Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Dashenlin Pharm Grp Co Ltd.

Receive notifications about Dashenlin Pharm Grp Co Ltd in your mailbox!